HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia

Autor: Qian Lai, Hongyu Ni, Shi Chen, Ying Guo, Huacheng Luo, Yi Qiu, Feng Chun Yang, David F. Claxton, Ganqian Zhu, Yang Feng, Suming Huang, Ru Feng, Jianfeng Xu, Bing Xu, Olga A. Guryanova, Stephen D. Nimer, Arati Sharma, Zhigang Zhao, Ruben A. Mesa, Wei Li, Mingjiang Xu
Jazyk: angličtina
Rok vydání: 2021
Předmět:
0301 basic medicine
Transcription
Genetic

Carcinogenesis
General Physics and Astronomy
Histones
Mice
0302 clinical medicine
Transcription (biology)
hemic and lymphatic diseases
Gene expression
Myeloid Ecotropic Viral Integration Site 1 Protein
Promoter Regions
Genetic

Regulation of gene expression
Myelopoiesis
Multidisciplinary
Chemistry
Gene Expression Regulation
Leukemic

Myeloid leukemia
Nuclear Proteins
Chromatin
Cell biology
Stem-cell research
Leukemia
Leukemia
Myeloid
Acute

030220 oncology & carcinogenesis
Multigene Family
Self-renewal
Heterografts
RNA
Long Noncoding

Nucleophosmin
Myeloid-Lymphoid Leukemia Protein
Signal Transduction
NPM1
Science
Mice
Transgenic

General Biochemistry
Genetics and Molecular Biology

Article
Acute myeloid leukaemia
03 medical and health sciences
Cell Line
Tumor

medicine
Animals
Humans
Cancer models
Cell Proliferation
Homeodomain Proteins
Gene Expression Profiling
General Chemistry
Histone-Lysine N-Methyltransferase
medicine.disease
030104 developmental biology
Mutation
Zdroj: Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-17 (2021)
ISSN: 2041-1723
Popis: Nucleophosmin (NPM1) is the most commonly mutated gene in acute myeloid leukemia (AML) resulting in aberrant cytoplasmic translocation of the encoded nucleolar protein (NPM1c+). NPM1c+ maintains a unique leukemic gene expression program, characterized by activation of HOXA/B clusters and MEIS1 oncogene to facilitate leukemogenesis. However, the mechanisms by which NPM1c+ controls such gene expression patterns to promote leukemogenesis remain largely unknown. Here, we show that the activation of HOXBLINC, a HOXB locus-associated long non-coding RNA (lncRNA), is a critical downstream mediator of NPM1c+-associated leukemic transcription program and leukemogenesis. HOXBLINC loss attenuates NPM1c+-driven leukemogenesis by rectifying the signature of NPM1c+ leukemic transcription programs. Furthermore, overexpression of HoxBlinc (HoxBlincTg) in mice enhances HSC self-renewal and expands myelopoiesis, leading to the development of AML-like disease, reminiscent of the phenotypes seen in the Npm1 mutant knock-in (Npm1c/+) mice. HoxBlincTg and Npm1c/+ HSPCs share significantly overlapped transcriptome and chromatin structure. Mechanistically, HoxBlinc binds to the promoter regions of NPM1c+ signature genes to control their activation in HoxBlincTg HSPCs, via MLL1 recruitment and promoter H3K4me3 modification. Our study reveals that HOXBLINC lncRNA activation plays an essential oncogenic role in NPM1c+ leukemia. HOXBLINC and its partner MLL1 are potential therapeutic targets for NPM1c+ AML.
Nucleophosmin (NPM1) gene mutation induces a specific gene expression program leading to acute myeloid leukaemia. Here, the authors show that mutant NPM1 activates a HOXB locus-associated long non-coding RNA which is essential for its associated oncogenic transcriptional program and leukaemia development.
Databáze: OpenAIRE